Biochemical profile
| Test | Value | Reference range |
| CRP (mg/L) | 42 (day 1) 79.9 (day 5) 11.5 (day 12) | <8 |
| Alanine aminotransferase (U/L) | 73 | 10–70 |
| Monocytes (×109/L) | 0.84 | 0.2–0.7 |
| Leucocytes (×109/L) | 7.05 | 3.5–10 |
| Neutrophils (×109/L) | 4.66 | 2–7 |
| Eosinophils (×109/L) | <0.02 | <0.5 |
| Basophils (×109/L) | <0.02 | <0.1 |
| Lymphocytes (×109/L) | 1.51 | 1.3–3.5 |
| Thrombocytes (×109/L) | 221 | 145–350 |
| Haemoglobin (g/L) | 145 | 134–169 |
| Erythrocyte sedimentation rate (mm/hour) | 57 | <20 |
| Reticulocytes (×1012/L) | 0.029 | 0.036–0.113 |
| Haptoglobin (g/L) | >3.4 | 0.47–2.05 |
| Ferritin (µg/L) | 2641 | 22–355 |
| Transferrin (µmol/L) | 18 | 24–41 |
| Plasma iron (µmol/L) | 3 | 9–34 |
| Blood glucose (mmol/L) | 5.4 | 4.2–7.8 |
| Plasma creatinine (µmol/L) | 87 | 60–105 |
| eGFR (mL/min) | 73 | >60 |
| Plasma kappa chain (Ig) (free) (mg/L) | 36.4 | 3.3–19.4 |
| Plasma lambda chain (Ig) (free) (mg/L) | 23.1 | 5.7–26.3 |
| Plasma kappa chain to lambda chain ratio (Ig) (free) | 1.58 | 0.26–1.65 |
| IgM (g/L) | 0.15 | 0.39–2.08 |
| High-density lipoprotein (mmol/L) | 0.87 | >1 |
Day 1 indicates first contact to general practice. CRP development is denoted, and the rest are results from day 5.
The following tests were normal: HbA1c, INR, potassium, sodium, alkaline phosphatase, total bilirubin, TSH, antinuclear antibodies, IgA, urate, alpha-fetoprotein, HBsAg, anti-HCV, HAV-IgM, folate, amylase, M component, IgG, cobalamin (B12), PSA, albumin and human choriogonadotropin.
CRP, C reactive protein; eGFR, estimated glomerular filtration rate; HAV, hepatitis A virus; HbA1c, Haemoglobin A1c; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; INR, international normalized ratio; PSA, prostate specific antigen; TSH, thyroid stimulating hormone.